Abstract
The most common cause of chronic renal failure (CRF) among patients who are starting on dialysis in developed countries is diabetes mellitus (DM), with growing rates approaching 50%. In Brazil, the available data indicate a lower prevalence, around 27%, even though it is also increasing. To estimate the prevalence of DM in the adult population of patients on hemodialysis for CRF in Porto Alegre, Brazil. Cross-sectional, descriptive, quantitative and analytical survey study on the prevalence of DM among the 1,288 patients on hemodialysis (HD) in all the 15 clinics in the city from June to July, 2009. 488 diabetic patients were identified, a prevalence of 37.9%, ranging from 21 - 75% in the different clinics of the city. The prevalence of DM among chronic HD patients in Porto Alegre is higher than what was previously published as a cause of CRF in the country, which indicates the possibility that this etiology of CRF may have been underestimated.
Highlights
The most common cause of chronic renal failure (CRF) among patients who are starting on dialysis in developed countries is diabetes mellitus (DM), with growing rates approaching 50%
Este estudo transversal foi realizado no período de junho a julho de 2009, em todas as quinze clínicas de diálise da cidade de Porto Alegre, incluindo dados individualizados por serviço e da totalidade dos pacientes em tratamento de insuficiência renal crônica (IRC) com HD ambulatorial intermitente
No período do estudo – entre junho e julho de 2009 – 1.288 pacientes renais crônicos foram informados como estando em tratamento com HD nas quinze diferentes clínicas da cidade de Porto Alegre
Summary
The most common cause of chronic renal failure (CRF) among patients who are starting on dialysis in developed countries is diabetes mellitus (DM), with growing rates approaching 50%. O presente estudo teve por objetivo estimar a prevalência de DM nos pacientes com IRC em programa de HD na cidade de Porto Alegre, Brasil e sua distribuição pelos diferentes centros de tratamento da cidade.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
